Medical-Enterprise Collaboration Promotes Standardized Application of Surgical Robots and International Talent Development
BeijingMay 22, 2026 /PRNewswire/ — Recently, Johnson & Johnson MedTech signed a strategic cooperation memorandum with Beijing Shijitan Hospital, Capital Medical University, aiming to explore feasible strategic collaborations focused on the standardized application of surgical robots and the development of international talent. This includes discussions on jointly building China’s first training demonstration base for split-type surgical robots, concentrating on standardized clinical application of surgical robots and surgeon capacity building, to create a professional platform integrating clinical technical training and international academic exchange. This represents a proposed strategic collaboration between the two parties in discipline development and talent cultivation, promoting medical-enterprise cooperation to advance the standardized application of surgical robots, with the expectation of supporting the high-quality development of minimally invasive surgical technology.
Signing representatives from both parties sign the strategic cooperation memorandum
Zhang Qian, President of Beijing Shijitan Hospital, Capital Medical University, stated: “This strategic collaboration will become an ongoing practice for our hospital to advance the application of innovative technologies and strengthen standardized talent development, actively responding to national initiatives to improve medical service quality and promote the standardized development of medical technologies. We believe that with the support and cooperation of Johnson & Johnson MedTech, we will further leverage the platform’s role to promote standardized training and international academic exchange in the field of surgical robots, facilitate two-way exchange of clinical experience and cutting-edge concepts, and provide sustained momentum for the high-quality development of China’s minimally invasive surgery field.”
Beijing Shijitan Hospital, Capital Medical University, has already implemented practices in the clinical application and talent development of surgical robots across multiple disciplines, including urology, hepatobiliary and pancreatic surgery, thoracic surgery, and orthopedics. This strategic collaboration is expected to utilize the Haishan-1® split-type endoscopic surgical robot, combining the hospital’s practical foundation in disease diagnosis, treatment, and clinical teaching with the collaborating enterprise’s systematic capabilities in professional education, international training standards, and global academic networks. This will promote the scaled-up upgrade and international expansion of the hospital’s existing training system, further refine a talent development model oriented by clinical needs, and provide long-term support for continuous physician growth and improvement in surgical treatment quality.
As a long-term participant deeply rooted in China’s surgical field for over three decades, Johnson & Johnson MedTech leverages its century-long accumulation in surgery to continuously improve comprehensive surgical solutions and accelerate innovation, expanding the boundaries of surgical treatment with minimally invasive surgical technologies, including surgical robots and other innovative capabilities. At the same time, drawing on its long-standing practice and experience in professional education, it collaborates with clinical partners to explore new models for standardized training and talent development in surgical robots, thereby promoting innovative development in the surgical field.
Owen Li, General Manager of the Surgical Business Unit at Johnson & Johnson MedTech China, stated: “This strategic collaboration marks a new, future-oriented phase in our years of partnership with Beijing Shijitan Hospital, Capital Medical University. We look forward to continuing our joint efforts to inject sustained new momentum into the development of the surgical workforce and the high-quality advancement of the discipline.”